• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»A3 adenosine receptor

Is Can-Fite BioPharma Ltd. building a differentiated niche in late-line pancreatic cancer therapy

By Soujanya Ravi on April 30, 2026   Pharma & Biotech  

Is Can-Fite BioPharma Ltd. building a differentiated niche in late-line pancreatic cancer therapy

Is Can-Fite BioPharma Ltd. carving a niche in pancreatic cancer? Explore how namodenoson’s Phase 2a data could reshape late-line treatment strategies.

Recent Posts

  • Why 3Shape’s Dx Software clearance matters for digital dentistry’s next phase
  • FDA clears Olympus POWERSEAL Open Extended Jaw as surgical energy competition grows
  • Rezolute’s ersodetug data deepens the congenital hyperinsulinism regulatory debate
  • How Arvinas and Pfizer’s VEPPANU approval tests the commercial future of PROTAC drugs
  • Can Arvinas, Inc. and Pfizer Inc. scale protein degradation in oncology markets
  • Does Rhythm Pharmaceuticals, Inc. now lead the rare neuroendocrine obesity treatment space?
  • Is Noema Pharma AG building a multi-symptom menopause therapy platform with cendifensine?
  • Is BRC Therapeutics opening a new regulatory lane for cannabinoid-based CRPS therapies?
  • Does MapLight Therapeutics, Inc. have the clinical design to compete in crowded neuropsychiatric markets?
  • Why PreludeDx’s second FDA breakthrough device designation matters for precision diagnostics
  • What Orchestra BioMed Holdings, Inc.’s AVIM strategy reveals about the future of hypertension device innovation
  • Is Can-Fite BioPharma Ltd. building a differentiated niche in late-line pancreatic cancer therapy
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes